By: Khushbu Sharma, Swati Daniel, and Ranjitham Anderson. S
1Incharge Nurse, Department of Nursing, Apollo Hospital, Bilaspur
2Nursing Superintendent, Department of Nursing, Apollo Hospital, Bilaspur
3Deputy Chief Nursing Officer, Department of Nursing, Apollo Cancer Centre Tentynampet Chennai, India
Thrombolytic medications work by breaking down large blood clots, allowing blood to flow back to the heart and reducing the risk of heart muscle damage. These agents can help prevent a heart attack from progressing to a myocardial infarction, which can be life-threatening. Fibrinolytic drugs are the preferred treatment for STEMI, as they promote reperfusion and restore blood flow when given within 12 hours of symptom onset. A 12- hour window-time for administration of thrombolytic remedy is now extensively accepted. The failure to thrive overview showed that thrombolytic remedy reduced mortality by 14% ( S D 5%) in clients randomized between 7 and 12 hours after the onset of symptoms. Investigators conducted a study to dissect compliance with timing of thrombolytic loading dose within 60 minutes among patients with acute myocardial infarction and its impact on patient outcomes whether the patient becomes stable or unstable. Quantitative approach and Retrospective study design was used.30 samples were selected using purposive sampling technique data collection was started after formal approval from ethical committee, nursing and medical head. Data collected was analyzed using descriptive statistic and it revealed that out of 30 patient, 21 patients received the loading dose within 30 minutes,4 patients received within 31 to 60 minutes and 5 patients received within 2 hours and with record to the patient outcomes 93% patient were stable and 7% were unstable. The study and results revealed that all patients who have received thrombolytic therapy within the first 60 minutes (golden hour) after initial symptom of chest pain had better outcomes, less morbidity and fewer complication, suggesting the need and importance of intervention during the golden hour. In this regard, Apollo Hospitals Bilaspur has been organizing CME’S in peripheral / rural areas to promote patient and doctors’ awareness and in regard to the golden hour and its importance.
Keywords: Myocardial infarction, ST elevated- Myocardial infarction, failure to thrive, acute myocardial infarction, thrombolytic therapy.
Citation:
Refrences:
1. Thygesen K etal Universal definition of myocardial infarction. Circulation. 2007 Nov 27;116(22):2634-53.
2. Reimer KA, Jennings RB, Tatum AH. Pathobiology of acute myocardial ischemia: metabolic, functional and ultrastructural studies. Am J Cardiol. 1983 Jul 20;52(2):72A-81A.
3. Fuster V. Gotto A.M. Libby P. Loscalzo J. McGill H.C. 27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events. Pathogenesis of coronary disease: the biologic role of risk factors J Am Coll Cardiol 1996 27 964 976.Braunwald E. Jones R.H. Mark D.B. et al. Diagnosing and managing unstable angina Circulation 1994 90 613 622.
4. Sianos, G. et al. Angiographic stent thrombosis after routine use of drug-eluting stents in ST-segment elevation myocardial infarction: The importance of thrombus burden. J. Am. Coll. Cardiol. 50, 573–583. https://doi.org/10.1016/j.jacc.2007.04.059 (2007).
5. Ibanez, B. et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur. Heart J. 39, 119–177. https://doi.org/10.1093/eurheartj/ehx393 (2018).
6. Stussman BJ National Center for Health Statistics, authors; National hospital ambulatory medical care survey, authors. emergency department summary. Advance data from vital and health statistics. No. 285. Hyattsville, Md: Public Health Service; 1997. (DHHS publication no. (PHS) 97-1250.) Pope JH, Aufderheide TP, Ruthazer R, Woolard RH, Feldman JA, Beshansky JR, et al. Missed diagnoses of acute cardiac ischemia in the emergency department. N Engl J Med. 2000;342:1163–1170. Pozen MW, D’Agostino RB, Selker HP, Sytkowski PA, Hood WB. A predictive instrument to improve coronary-care-unit admission practices in acute ischemic heart disease A prospective multicenter clinical trial. N Engl J Med. 1984;310(20):1273–1278.
7. Morrison LJ, Verbeek PR, McDonald AC, Sawadsky BV, Cook DJ. Mortality and prehospital thrombolysis for acute myocardial infarction: A meta-analysis. JAMA. 2000;283(20):2686–2692. [see comment].
8. Virani SS et al. ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 appropriate use criteria for coronary revascularization in patients with stable ischemic heart disease : a report of the American college of cardiology appropriate use criteria task force, American association for thoracic surgery, American heart association, American society of echocardiography, American society of nuclear cardiology, society for cardiovascular angiography and interventions, society of cardiovascular computed tomography, and society of thoracic surgeons. J Nucl Cardiol Off Publ Am Soc Nucl Cardiol. (2017) 24:1759–92. doi: 10.1007/s12350-017-0917-9
9. Prehospital management of acute ST-elevation myocardial infarction: a time for reappraisal in North America. Welsh RC, Ornato J, Armstrong PW. Am Heart J. 2003;145:1–8.
10. Thrombolysis for acute myocardial infarction. White HD, Van de Werf FJ. Circulation. 1998;97:1632–1646.
